Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002867008 | SCV003235190 | pathogenic | Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C | 2022-09-30 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with GPHN-related conditions. This sequence change creates a premature translational stop signal (p.Gln211Serfs*3) in the GPHN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPHN are known to be pathogenic (PMID: 11095995, 23184456, 23393157). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. |